Ingalls & Snyder LLC Novavax Inc Transaction History
Ingalls & Snyder LLC
- $2.56 Billion
- Q3 2024
A detailed history of Ingalls & Snyder LLC transactions in Novavax Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 7,500 shares of NVAX stock, worth $65,400. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,500Holding current value
$65,400% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
291Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$135 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$103 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$85.6 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$67 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$51.8 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $682M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...